mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.9 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0002 |